149 related articles for article (PubMed ID: 27496148)
1. Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study.
Singh D; Pitkäniemi J; Malila N; Anttila A
Breast Cancer Res Treat; 2016 Sep; 159(2):305-13. PubMed ID: 27496148
[TBL] [Abstract][Full Text] [Related]
2. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
4. Cumulative risks of false positive recall and screen-detected breast cancer after multiple screening examinations.
Kregting LM; van Ravesteyn NT; Chootipongchaivat S; Heijnsdijk EAM; Otten JDM; Broeders MJM; de Koning HJ
Int J Cancer; 2023 Jul; 153(2):312-319. PubMed ID: 37038266
[TBL] [Abstract][Full Text] [Related]
5. Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer.
Ripping TM; Hubbard RA; Otten JD; den Heeten GJ; Verbeek AL; Broeders MJ
Int J Cancer; 2016 Apr; 138(7):1619-25. PubMed ID: 26537645
[TBL] [Abstract][Full Text] [Related]
6. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
[TBL] [Abstract][Full Text] [Related]
7. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
8. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
9. Association of symptoms and breast cancer in population-based mammography screening in Finland.
Singh D; Malila N; Pokhrel A; Anttila A
Int J Cancer; 2015 Mar; 136(6):E630-7. PubMed ID: 25160029
[TBL] [Abstract][Full Text] [Related]
10. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
[TBL] [Abstract][Full Text] [Related]
11. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.
Otten JDM; Fracheboud J; den Heeten GJ; Otto SJ; Holland R; de Koning HJ; Broeders MJM; Verbeek ALM
Ann Oncol; 2013 Oct; 24(10):2501-2506. PubMed ID: 23788759
[TBL] [Abstract][Full Text] [Related]
12. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis.
Singh D; Malila N; Pitkäniemi J; Anttila A
Int J Cancer; 2019 Jun; 144(12):2928-2935. PubMed ID: 30511466
[TBL] [Abstract][Full Text] [Related]
14. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
Tsuruda KM; Larsen M; Román M; Hofvind S
Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
[TBL] [Abstract][Full Text] [Related]
15. Risk of breast cancer after false-positive results in mammographic screening.
Román M; Castells X; Hofvind S; von Euler-Chelpin M
Cancer Med; 2016 Jun; 5(6):1298-306. PubMed ID: 26916154
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with false-positive mammography at first screen in an Asian population.
Ho PJ; Bok CM; Ishak HMM; Lim LY; Liu J; Wong FY; Chia KS; Tan MH; Chay WY; Hartman M; Li J
PLoS One; 2019; 14(3):e0213615. PubMed ID: 30856210
[TBL] [Abstract][Full Text] [Related]
17. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
[TBL] [Abstract][Full Text] [Related]
18. Nonhomogeneous Markov chain for estimating the cumulative risk of multiple false positive screening tests.
Golmakani MK; Hubbard RA; Miglioretti DL
Biometrics; 2022 Sep; 78(3):1244-1256. PubMed ID: 33939839
[TBL] [Abstract][Full Text] [Related]
19. Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.
Sprague BL; Chen S; Miglioretti DL; Gard CC; Tice JA; Hubbard RA; Aiello Bowles EJ; Kaufman PA; Kerlikowske K
JAMA Netw Open; 2023 Feb; 6(2):e230166. PubMed ID: 36808238
[TBL] [Abstract][Full Text] [Related]
20. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
Castells X; Molins E; Macià F
J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
